Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 23, 2018JAMAOpen Access

Effect of Prolonged Exposure Therapy Delivered Over 2 Weeks vs 8 Weeks vs Present-Centered Therapy on PTSD Symptom Severity in Military Personnel

View Full Paper
Ask AI
Bookmark
Share

Authors

Edna B. Foa
Edna B. FoaFlorida State University
CMCarmen P. McLeanPalo Alto UniversityYZYinyin ZangMinistry of Education

Discussion

Loading...

Member takes

Overview

Randomized noninferiority trial shows massed exposure therapy reduces PTSD symptoms similarly to spaced therapy in military personnel, indicating compressed treatment schedules are viable.

Key Points

  • To evaluate the efficacy and noninferiority of massed prolonged exposure therapy (2 weeks) compared with spaced prolonged exposure therapy (8 weeks), present-centered therapy, and minimal-contact control in military personnel with PTSD.
  • Randomized clinical trial (NCT01049516) conducted at Fort Hood, Texas, enrolling 370 active duty military personnel with combat-related PTSD returning from Iraq, Afghanistan, or both (analyzed n=366).
  • Participants were randomized to massed prolonged exposure (n=110; 10 sessions over 2 weeks), spaced prolonged exposure (n=109; 10 sessions over 8 weeks), present-centered therapy (n=107; 10 sessions over 8 weeks), or minimal-contact control (n=40; weekly phone calls for 4 weeks).
  • Primary outcome was PTSD symptom severity measured by the PTSD Symptom Scale-Interview (PSS-I, range 0-51; noninferiority margin 2.3 points with 1-sided α = .05) assessed through 6-month follow-up.
  • At 2 weeks posttreatment, massed therapy reduced PSS-I scores significantly more than minimal-contact control (mean score 17.62 vs 21.41; decrease difference, 3.70 [95% CI, 0.72 to 6.68]; P = .02).
  • Massed therapy was noninferior to spaced therapy at 2 weeks posttreatment (mean score 17.62 vs 18.03; difference, 0.79 [1-sided 95% CI, -∞ to 2.29; P = .049 for noninferiority]) and at 12 weeks posttreatment (mean score 18.88 vs 18.34; difference, 0.55 [1-sided 95% CI, -∞ to 2.05; P = .03 for noninferiority]).
  • Spaced therapy showed no significant difference compared to present-centered therapy at posttreatment (mean PSS-I score 18.03 vs 18.65; difference in decrease, 0.10 [95% CI, -2.48 to 2.27]; P = .93).

Cite This Study

Foa et al. (2018) studied this question.

synapsesocial.com/papers/6a7d0c5a2c71273e4183d3fbhttps://doi.org/10.1001/jama.2017.21242
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The control of the false discovery rate in multiple testing under dependency2001 · 10,966 citations
  2. 2Association of Posttraumatic Stress Disorder With Somatic Symptoms, Health Care Visits, and Absenteeism Among Iraq War Veterans2007 · 778 citations
  3. 3Treatment of posttraumatic stress disorder in rape victims: A comparison between cognitive-behavioral procedures and counseling.1991 · 1,173 citations